Literature DB >> 2296380

Age-induced cognitive disturbances in Parkinson's disease.

B Dubois1, B Pillon, N Sternic, F Lhermitte, Y Agid.   

Abstract

We investigated the influence of age on the occurrence of cognitive disturbances in Parkinson's disease (PD), by evaluating neuropsychological performances in early- and late-onset groups of patients (less than 45 and greater than 65 years, respectively), individually paired for all the variables of parkinsonism and compared with age-matched controls. Cognitive disorders were limited in the early-onset PD group compared with their age-matched controls. Conversely, we found global cognitive changes, including marked frontal lobe dysfunction, in the late-onset group. This specific cognitive impairment in older patients related to a significant interaction between the aging and disease processes. Late onset seemed to compound the subtle cognitive changes associated with the disease for which the early-onset group compensated. This compounding effect of aging may explain, at least partially, the high frequency of dementia in older PD patients.

Entities:  

Mesh:

Year:  1990        PMID: 2296380     DOI: 10.1212/wnl.40.1.38

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?

Authors:  Francesca Di Biasio; Nicola Vanacore; Alfonso Fasano; Nicola Modugno; Barbara Gandolfi; Francesco Lena; Giovanni Grillea; Sara Pietracupa; Giovanni Caranci; Stefano Ruggieri
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

2.  Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's disease.

Authors:  L Sagliocco; F Bandini; M Pierantozzi; Z Mari; A Tzelepi; C Ko; J Gulzar; I Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Low FAB score as a predictor of future falling in patients with Parkinson's disease: a 2.5-year prospective study.

Authors:  Hiroshi Kataoka; Satoshi Ueno
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

Review 4.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

5.  The relationship between visuospatial ability and perceptual motor function in Parkinson's disease.

Authors:  M Richards; L J Cote; Y Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

6.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

7.  Does ageing aggravate parkinsonian disability?

Authors:  J Blin; B Dubois; A M Bonnet; M Vidailhet; M Brandabur; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

8.  Anticholinergic therapy and dementia in patients with Parkinson's disease.

Authors:  M Pondal; T Del Ser; F Bermejo
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

9.  Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age.

Authors:  Jae Woo Kim; Sang Myung Cheon; Min Jeong Park; Seong Yeon Kim; Hee Young Jo
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077

10.  Which factors predict cognitive decline in Parkinson's disease?

Authors:  D Caparros-Lefebvre; N Pécheux; V Petit; A Duhamel; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.